Table 3 ITN use and self-medication with anti-malarial drug prevalence according to the age
2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|
Self-medication, n (%) | ||||
< 5 years | 129 (11.9) | 280 (23.1) | 627 (23.8) | 595 (20.2) |
5–10 years | 63 (15.2) | 133 (29.2) | 357 (34.3) | 328 (28.9) |
11–18 years | 41 (17.6) | 77 (30.4) | 112 (28.8) | 167 (29.7) |
p | 0.03 | < 0.01 | < 0.01 | < 0.01 |
ITN use, n (%) | ||||
< 5 years | 625 (58.0) | 694 (57.0) | 1332 (50.8) | 1649 (55.8) |
5–10 years | 207 (50.1) | 196 (42.5) | 414 (40.3) | 471 (41.3) |
11–18 years | 114 (49.1) | 104 (40.5) | 158 (40.8) | 182 (31.6) |
p | 0.003 | < 0.01 | < 0.01 | < 0.01 |